Forskning ved Københavns Universitet - Københavns Universitet

Forside

Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Worldwide, more than 400 million individuals have allergic rhinitis, which has a significant impact on the individual's general health. Most patients self-medicate with over-the-counter drugs, but severe cases need treatment with topical corticosteroids and/or immunotherapy (SCIT). Although the ARIA guidelines discourage the use of systemic corticosteroids, this treatment is often used by general practitioners.
OriginalsprogEngelsk
TidsskriftAllergy: European Journal of Allergy and Clinical Immunology
Vol/bind67
Udgave nummer11
Sider (fra-til)1423-9
Antal sider7
ISSN0105-4538
DOI
StatusUdgivet - 2012

ID: 48420676